Admission Date:  [**2181-1-31**]     Discharge Date:  [**2181-2-12**]  Date of Birth:   [**2118-11-28**]     Sex:  M  Service:  Transplant  HISTORY OF PRESENT ILLNESS:  Mr. [**Known lastname **] is a 62-year-old male with a past medical history significant for end stage renal disease secondary to diabetes mellitus who presents today for a cadaveric renal transplantation.
The patient's past medical history is notable for coronary artery disease with placement of a sirolimus coated stent in [**2180-6-13**].
Underwent a successful cardiac workup including a stress test in [**2180-10-14**] which demonstrated no reversible profusion defects.
Coronary artery disease, status post myocardial infarction and stent placement.
Aspirin 325 mg p.o.
Atenolol 25 mg p.o.
Neurontin 200 mg p.o.
Renagel 800 mg p.o.
Erythropoietin q. hemodialysis.
ALLERGIES:  The patient has allergies to penicillin and intravenous contrast.
HOSPITAL COURSE:  The patient underwent a cadaveric renal transplantation on the day of admission.
The operation was complicated by postoperative hypotension requiring a two day stay in the Surgical Intensive Care Unit with the use of a Neo-Synephrine drip to maintain a systolic blood pressure greater than 110, and elevated potassium at 6.7, and a low urinary output.
The patient was weaned off of the Neo-Synephrine overnight, was dialyzed and was treated with Kayexalate.
His pain was well controlled in the postoperative state using a morphine PCA pump.
He was treated with six doses of ATG along with a Solu-Medrol taper, CellCept, and eventually Imuran and Prograf for immunosuppression.
His urine output improved from 130 cc the day following his surgery to 1700 cc daily at the time of discharge.
He remained afebrile with adequate blood pressure and blood sugar control throughout his stay and was discharged to home on postoperative day number 12 with a visiting nurse [**First Name (Titles) **] [**Last Name (Titles) **] with blood draws, and JP drain care.
An nasogastric tube was placed at this time but was subsequently removed the following day after a successful bowel movement.
End stage renal disease status post cadaveric renal transplantation.
Bactrim single strength one tablet p.o.
Protonix 40 mg p.o.
Colace 100 mg p.o.
Regular insulin sliding scale as directed.
Percocet 5/325 one to two tablets p.o.
Prednisone 20 mg p.o.
Valganciclovir 450 mg p.o.
Nystatin 5 cc p.o.
Imuran 100 mg p.o.
Prograf 3 mg p.o.
Neurontin 300 mg p.o.
Ativan 0.5 mg p.o.
DISCHARGE DISPOSITION:  The patient was discharged to home with visiting nurse services to [**Last Name (un) **] with blood draws and blood sugar monitoring along with wound care injection by drain care.
